These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9293273)

  • 1. Don't forget the hepatitis A vaccine.
    Thompson SC; Le Leu LA
    Med J Aust; 1997 Aug; 167(4):228-9. PubMed ID: 9293273
    [No Abstract]   [Full Text] [Related]  

  • 2. Don't forget the hepatitis A vaccine.
    McAnulty JM; Conaty SJ
    Med J Aust; 1998 Apr; 168(7):363-4. PubMed ID: 9577449
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic models of hepatitis A virus immunization.
    O'Connor JB; Imperiale TF; Singer ME
    Hepatology; 1999 Jul; 30(1):343-5. PubMed ID: 10428627
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination against hepatitis A for travellers. All relevant costs and consequences should be measured.
    Hardie R
    BMJ; 1995 Jan; 310(6971):61-2. PubMed ID: 7827577
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis A: epidemiology and prevention.
    Feinstone SM
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):300-5. PubMed ID: 8781894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should British soldiers be vaccinated against hepatitis A? An economic analysis.
    Jefferson TO; Behrens RH; Demicheli V
    Vaccine; 1994 Nov; 12(15):1379-83. PubMed ID: 7887014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A vaccine for secondary hepatitis A infection.
    Bell BP; Margolis HS
    Lancet; 1999 Jul; 354(9175):341; author reply 342-3. PubMed ID: 10440343
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis A vaccine for secondary hepatitis A infection.
    Shouval D; Ashur Y
    Lancet; 1999 Jul; 354(9175):342-3. PubMed ID: 10440345
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis A vaccine for secondary hepatitis A infection.
    Monto AS; Victor JC
    Lancet; 1999 Jul; 354(9175):341-2; author reply 342-3. PubMed ID: 10440344
    [No Abstract]   [Full Text] [Related]  

  • 11. An economic evaluation of hepatitis A vaccination in Dutch military personnel.
    Buma AH; Beutels P; van Damme P; Tormans G; van Doorslaer E; Leentvaar-Kuijpers A
    Mil Med; 1998 Aug; 163(8):564-7. PubMed ID: 9715622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Who in The Netherlands is eligible for immunization with inactivated hepatitis A vaccine?].
    Leentvaar-Kuijpers A
    Ned Tijdschr Geneeskd; 1994 May; 138(19):941-2. PubMed ID: 8196784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inactivated antihepatitis A vaccine].
    Escolar M; Sádaba B; Honorato J
    Rev Med Univ Navarra; 1995; 40(2):110-4. PubMed ID: 7569545
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JA; Ruiz Extremera A
    Gastroenterol Hepatol; 1997 Nov; 20(9):467-73. PubMed ID: 9445743
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination against hepatitis A for travellers. Will alter the dynamics of transmission in Britain.
    Neal K
    BMJ; 1995 Jan; 310(6971):61. PubMed ID: 7827576
    [No Abstract]   [Full Text] [Related]  

  • 16. A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination.
    Saab S; Martin P; Yee HF
    Am J Med; 2000 Aug; 109(3):241-4. PubMed ID: 10974188
    [No Abstract]   [Full Text] [Related]  

  • 17. An economic evaluation of vaccination against hepatitis A for frequent travellers.
    Fenn P; McGuire A; Gray A
    J Infect; 1998 Jan; 36(1):17-22. PubMed ID: 9515663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine.
    Kurup A; San LM; Yew WS
    Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of hepatitis A].
    Wagner G
    Rev Med Suisse Romande; 1993 Mar; 113(3):191-2. PubMed ID: 8386849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.